The U.S. Food and Drug Administration (FDA) today announced the approval of Tekturna (aliskiren) tablets for the treatment of high blood pressure, or hypertension, which affects an estimated 25 percent of Americans and causes increased risk of stroke, heart attack, kidney failure, heart failure and death.
Home » Pharma/FDA News » FDA Approves New Drug Treatment for High Blood Pressure
Subscribe to: Post Comments ( Atom )
0 comments :
Post a Comment